IOVANCE BIOTHERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $1.6M | $105.7M | $33.6M |
| FY2016 | $5.0M | $171.9M | $106.7M |
| FY2017 | $9.9M | $155.4M | $145.4M |
| FY2018 | $14.6M | $480.8M | $82.2M |
| FY2019 | $45.7M | $344.7M | $14.0M |
| FY2020 | $112.0M | $768.5M | $67.3M |
| FY2021 | $155.7M | $777.3M | $78.2M |
| FY2022 | $164.3M | $664.0M | $231.7M |
| FY2023 | $195.7M | $780.4M | $114.9M |
| FY2024 | $200.0M | $910.4M | $115.7M |